We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Ultra-Sensitive Rapid Test Evaluated for Malaria

By LabMedica International staff writers
Posted on 05 Apr 2018
In low prevalence regions, subpatent Plasmodium falciparum malaria infections have become an issue of increasing concern. More...
As malaria endemic countries shift from control to elimination, the proportion of low-density P. falciparum infections increases.

Current field diagnostic tools, such as microscopy and rapid diagnostic tests (RDT), with detection limits of approximately 100 to 200 parasites/µL (p/µL) and 800 to1000 pg/mL histidine-rich protein 2 (HRP2), respectively, are unable to detect subpatent infections.

Scientists at Diagnostics Program, PATH (Seattle, WA, USA) tested two commercial available RDTs. The two RDTs are immunochromatographic membrane strip tests, but differ in that the ultra-sensitive (uRDT) one uses biotinylated and carboxyl-modified latex fragment antibodies (FAbs) and polystreptavidin bound to the test line to detect P. falciparum-specific HRP2 in whole blood. The uRDT test requires 5 µL of whole blood specimen and the blood is applied to the sample port in the test followed by application of four drops of assay diluent. Twenty minutes after application of the specimen, the result is interpreted from the result window.

The uRDT used was the Alere Malaria Ag P.f RDT and was compared to the BIOLINE Malaria Ag P.f RDT. The team reported that the uRDT detected dilutions of P. falciparum recombinant strains, as well as cultured strains, diluted in whole blood down to 10 to 40 pg/mL HRP2, depending on the protein tested. The uRDT specificity was 100% against 123 archived frozen whole blood samples. The commercial SD-RDT and uRDT detected pfhrp2 positive strains down to 49 and 3.13 p/µL, respectively. The pfhrp2 deletion strains were detected down to 98 p/µL by both tests.

The authors concludes that the performance of the uRDT was variable depending on the protein, but overall showed a greater than 10-fold improvement over the SD-RDT. The uRDT also exhibited excellent specificity and showed the same cross-reactivity with HRP3 as the SD-RDT. Together, the results support the uRDT as a more sensitive HRP2 test that could be a potentially effective tool in elimination campaigns. The study was published on March 17, 2018, in the Malaria Journal.

Related Links:
Diagnostics Program, PATH


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.